Lotus Pharmaceuticals, Inc.

OTC: LTUS · Healthcare · Medical - Pharmaceuticals

PublicHQ Nashville, TN · DavidsonCIK 0001292087Reports USD

#1 of 1,418 Healthcare companies by revenue

EA Score

——

FH —DQ —GM —SS 58

v0.1 · 5/100 weight · pillars only

↑ listing tenure, workforce scale · ↓ Altman-Z, market scale

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

—

Employees

233

as of 2026-08-28

Market cap

$82.3k

as of 2026-08-28

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

No filed financials — private or non-XBRL filer.

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

What is Lotus Pharmaceuticals, Inc.’s financial profile?

Lotus Pharmaceuticals, Inc. has no structured financials on file — private or non-XBRL filer.

Neighbors

Davidson →

HCA Healthcare, Inc.$75.6B78B+Ryman Hospitality Properties, Inc.$2.6B65B Healthcare Realty Trust Incorporated$28.2M64C Louisiana-Pacific Corporation$2.7B74B Atmus Filtration Technologies Inc.$1.8B60C AllianceBernstein Holding L.P.——

Key facts

CEOZhong Yi Liu

SectorHealthcare

IndustryMedical - Pharmaceuticals

HeadquartersNashville, TN

ExchangeOTC: LTUS

Employees233

IPO date2005-08-09

Latest filings

8-K2020-02-25 8-K2012-01-30 8-K2012-01-11 8-K2012-01-09 8-K2011-11-16 10-Q2011-11-10 8-K2011-08-17 10-Q2011-08-12

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.